Apoio

quinta, 08 fevereiro 2018 18:41
Posters

Trabalhos portugueses aceites no Congresso da ECCO

São várias as equipas e especialistas portugueses que terão os seus trabalhos apresentados na 13.ª edição do Congresso da ECCO, ao terem sido aceites para apresentação em formato poster. Mas também em sessões de digital oral presentation (DOP).

Em alguns casos, tratam-se de nomes portugueses que colaboraram em investigações multicêntricas, dando assim o contributo português em trabalhos de foro internacional.

Estes trabalhos receberam assim o aval positivo das comissões avaliadoras da ECCO fazendo parte dos 1012 abstracts aceites para neste congresso.

Apresentações em formato poster

 

P252 Assessment of ulcerative colitis using histological

Poster presentations: Clinical: Diagnosis and outcome (2018)

P545 Antigenic response to CT-P13 and remicade in inflammatory bowel disease patients shows similar epitope recognition

Poster presentations: Clinical: Therapy and observation (2018)

P229 The new biosimilar of infliximab SB2 can be quantified by IFX-optimised therapeutic drug monitoring assays

Poster presentations: Clinical: Diagnosis and outcome (2018)

P142 Danese’s “Red flag Instrument” is ready for clinical practice: the RFi prospective validation

Poster presentations: Clinical: Diagnosis and outcome (2018)

P173 Danese’s “Red flag Instrument” for early Crohn’s disease referral may also pick up ulcerative colitis patients – a prospective study

Poster presentations: Clinical: Diagnosis and outcome (2018)

P850 Genetic variants of MGAT5 gene are associated with ulcerative colitis severity and response to therapy

Poster presentations: Genetics (2018)

P014 Proinflammatory cytokines and bile salts inhibit the cellular uptake of butyrate by Caco-2 cells

Poster presentations: Basic science (2018)

P221 Histological indices in ulcerative colitis - useful in predicting long-term recurrence?

Poster presentations: Clinical: Diagnosis and outcome (2018)

P198 Are lower levels of faecal calprotectin reassuring in Crohn´s Disease patients?

Poster presentations: Clinical: Diagnosis and outcome (2018)

P311 Crohn’s disease: What can we expect from the course of the disease?

Poster presentations: Clinical: Diagnosis and outcome (2018)

P812 Natural disease course of inflammatory bowel disease unclassified in a prospective European population-based inception cohort—the Epi-IBD cohort

Poster presentations: Epidemiology (2018)

P402 Interstitial and granulomatous lung disease in inflammatory bowel disease patients

Poster presentations: Clinical: Therapy and observation (2018)

P555 Coagulation disorders in a population of patients with inflammatory bowel disease

Poster presentations: Clinical: Therapy and observation (2018)

P146 Ultrasonography and perianal involvement in inflammatory bowel disease

Poster presentations: Clinical: Diagnosis and outcome (2018)

P236 Symptoms of anxiety and depression in inflammatory bowel disease

Poster presentations: Clinical: Diagnosis and outcome (2018)

P290 Determination of small-bowel patency in Crohn’s disease - a prospective study

Poster presentations: Clinical: Diagnosis and outcome (2018)

P358 Factors associated with disability in inflammatory bowel disease (IBD): A cross-sectional study in outpatients

Poster presentations: Clinical: Diagnosis and outcome (2018)

P355 Prevalence, clinical characteristics and outcomes of CMV colitis in a cohort of 95 patients with ulcerative colitis: A 7-year retrospective analysis

Poster presentations: Clinical: Diagnosis and outcome (2018)

P878 Are cariogenic bacteria the major risk factor for dental caries in patients with ulcerative colitis?

Poster presentations: Microbiology (2018)

P414 Loss of response to anti-TNF in inflammatory bowel disease in a Portuguese centre

Poster presentations: Clinical: Therapy and observation (2018)

P537 Adalimumab: Relevance of drug trough levels and antibodies assessment in the prognosis of Crohn’s disease

Poster presentations: Clinical: Therapy and observation (2018)

P739 Early use of anti-TNF in Crohn’s disease is associated with higher rate of biological and endoscopic remission

Poster presentations: Clinical: Therapy and observation (2018)

P736 Point-of-care infliximab quantification in inflammatory bowel disease in daily practice

Poster presentations: Clinical: Therapy and observation (2018)

P720 Is there a difference in trough levels and immunogenicity between Crohn’s disease and ulcerative colitis patients treated with infliximab?

Poster presentations: Clinical: Therapy and observation (2018)

P126 Post-inflammatory polyps do not predict colorectal neoplasia in patients with inflammatory bowel disease: a multinational retrospective cohort study

Poster presentations: Clinical: Diagnosis and outcome (2018)

P168 Predicting outcome in acute severe ulcerative colitis: Comparison of the Oxford, Edinburgh, Lindgren and endoscopic Mayo scores

Poster presentations: Clinical: Diagnosis and outcome (2018)

P164 Into intimacy: Impact of IBD in sexual health

Poster presentations: Clinical: Diagnosis and outcome (2018)

P263 Evaluation of fatigue in inflammatory bowel disease: a useful tool in daily practice

Poster presentations: Clinical: Diagnosis and outcome (2018)

P285 Crohn’s disease overall severity is predictive of disabling disease: Disease severity index evaluation

Poster presentations: Clinical: Diagnosis and outcome (2018)

P873 The psycho-emotional experience of pregnancy in women with IBD and correlation with gut microbiome

Poster presentations: Microbiology (2018)

Digital Oral Presentations:

 

DOP019 Immunomodulators reduce the risk of surgery and hospitalisation in Crohn’s disease in a prospective European population-based inception cohort: the Epi-IBD cohort

DOP Session 3 - Old and new immunomodulators 2018

DOP087 The gut microbiota of pregnant women with Crohn’s disease and their babies is associated with abnormalities in the adaptive immune system: results from the MECONIUM study

DOP Session 10 - Microbes, food and cancer in IBD 2018

Agenda

fev14
13:00-18:00
Lehar 4, Congress Centre, Messe Wien
fev14
13:30-17:00
Lehar 2, Congress Centre, Messe Wien
fev14
13:30-16:30
Schubert 4-5, Congress Centre, Messe Wien
fev15
08:15-17:15
Stolz 1-2, Congress Centre, Messe Wien

Área Reservada

Portugueses no ECCO'18

Dr. Henrique Morna

Dr. Henrique Morna

Dr. João Sabino

Dr. João Sabino

Dr.ª Ana Paula Silva

Dr.ª Ana Paula Silva

Dr.ª Catarina Fidalgo

Dr.ª Catarina Fidalgo

Dr.ª Joana Carvão

Dr.ª Joana Carvão

Dr.ª Joana Torres

Dr.ª Joana Torres

Dr.ª Lídia Ramos

Dr.ª Lídia Ramos

Dr.ª Mafalda Sousa

Dr.ª Mafalda Sousa

Dr.ª Catarina Calle

Dr.ª Catarina Calle

Dr.ª Catia Arieira

Dr.ª Catia Arieira

Prof. Doutor Fernando Magro

Prof. Doutor Fernando Magro

Prof. Doutora Paula Borralho Nunes

Prof.ª Doutora Paula Borralho Nunes

Dr. Luis Correia

Dr. Luis Correia

Dr.ª Joana Afonso

Dr.ª Joana Afonso

Dr.ª Joana Roseira

Dr.ª Joana Roseira